|
Drug Topics
Community Pharmacists' Report
DrugTopics.com
November 9, 2011 |
MEDICATION ADHERENCE
A new medication adherence study found that 24% of patients given a new prescription did not fill it. This percentage is higher than what has been seen in earlier studies. » More
|
HEALTH PLANS
The National Association of Chain Drug Stores is backing new legislation that will offer incentives to states to use generic medications through Medicaid. » More
|
COMMUNITY PHARMACY
Health Mart, a franchise network of 2,900 independently owned pharmacies, has introduced its own line of private-label, over-the-counter healthcare products. The diabetes-care products will launch first to coincide with American Diabetes Month. » More |
ASSOCIATION NEWS
The American Pharmacists Association and the National Association of Boards of Pharmacy are developing a voluntary accreditation program for community pharmacies that is expected to be launched in 2012. » More |
Survey
a) Yes, it will definitely make a difference to the prescription drug shortages.
b) Yes, but it will take more than the order to fix the prescription drug shortages.
c) No, Congress should be enacting legislation to fix the prescription drug shortages.
d) No, the order will do little to help the prescription drug shortages.
Respond here and see what your colleagues think too.
Want to see the results of our last survey about the implications of the possible Express Scripts/Medco merger? Click here.
|
DIABETES MANAGEMENT
Healthcare Resources Online announced in a prepared statement that it is the engine powering the American Diabetes Association’s new service for its members, Diabetes Rx. » More |
CLINICAL NEWS
Eli Lilly and Company has announced a worldwide withdrawal of its drotrecogin alfa (activated) (Xigris) in all markets following results of the PROWESS-SHOCK study, which showed the study did not meet the primary end point of a statistically significant reduction in 28-day all-cause mortality in patients with septic shock. » More |
The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices voted to recommend that boys aged 11 to 12 years be vaccinated routinely with human papillomavirus (HPV) quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant (Gardasil, Merck) to help prevent cancer and other diseases caused by HPV. » More |
FDA ACTIONS
FDA has approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder. » More |
|
Digital Edition |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
|